More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.
Cecilia
C
Martín-Gandul
Emilio
E
García-Cabrera
Esperanza
E
Castillo-Ojeda
Manuel E
ME
Jiménez-Mejías
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D015163:Superinfection / Q000453:epidemiology*; D000078304:Tigecycline; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline